Occupational Insertion and Educational Level of Adult Patients With Pediatric Early Inflammatory Bowel Disease (IBD) (PROMICI)

May 20, 2026 updated by: University Hospital, Lille

The main objective of this project is to assess the occupational insertion of these adult patients with pediatric-onset IBD and to compare it with the general population.

The secondary objectives are:

  1. to assess the level of education and compare it to that of the general population
  2. to assess occupational insertion and the educational level according to:

    • The disease (Crohn's disease, ulcerative colitis or unclassified colitis)
    • sex
    • Age at diagnosis (<or ≥ 10 years)
    • The occurence of surgery, the location of the disease, the treatments undertaken
    • Quality of life
  3. Evaluate the patient's feelings about the impact of his illness on occupational insertion and the educational level
  4. To describe the quality of life of patients in relation to disease activity and health states (QALY calculation)
  5. To assess the responsivness to change of the functional handicap score IBD-DI (n = 200 patients)

Study Overview

Status

Completed

Detailed Description

Chronic inflammatory bowel diseases (IBD) are responsible for high morbidity and impaired quality of life of patients throughout disease course.

Numerous studies have shown the impact of the disease on the quality of life of patients with IBD. However, very little data is available on the level of education and professional integration of patients who started their IBD in childhood.

The hypothesis behind the study project is that the level of education and consequently the professional integration of patients with early pediatric IBD: 1) could be different from those of the general population; 2) and that these differences could be influenced by the nature of IBD, the age of its onset and its main characteristics.

The main objective of this project is to assess the professional integration of these adult patients with pediatric-onset IBD and to compare it with the general population.

Study Type

Observational

Enrollment (Actual)

343

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lille, France, 59037
        • Hop Jeanne de Flandre Chu Lille

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with pediatric-onset IBD (diagnosed before the age of 17) and aged over 25 at the time of the study.

Description

Inclusion Criteria:

  • Male or female, aged 25 and over at the time of the study
  • Subject listed in the EPIMAD registry suffering from certain or probable Crohn's disease, or certain or probable ulcerative colitis, or certain or probable ulcerated proctitis, unclassified colitis, diagnosed between 01/01 / 1988 and 12/31/2011, with an age at diagnosis of less than 17 years (definition of the pediatric cohort of the EPIMAD Registry)
  • Patient residing in the area of the EPIMAD registry: Nord, Pas-de-Calais, Somme or Seine-Maritime
  • Patient not opposed to the research
  • Patient not having objected to the use of their data for ancillary studies when registering in the EPIMAD register

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of active workers in employment
Time Frame: through study completion, an average of 18 months
Rate of active workers in employment collected using a standardized self-questionnaire
through study completion, an average of 18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Educational level
Time Frame: through study completion, an average of 18 months
Description of educational level collected using a standardized self-administered questionnaire
through study completion, an average of 18 months
Association between occupational insertion and disease variables
Time Frame: through study completion, an average of 18 months
Associated factors are : disease type (Crohn / Ulcerative colitis), gender, location of the disease at diagnosis, surgery, treatments, age at diagnosis
through study completion, an average of 18 months
Association between occupational insertion and quality of life
Time Frame: through study completion, an average of 18 months
Quality of life as measured by SIBDQ questionnaire.
through study completion, an average of 18 months
Association between educational level and disease variables
Time Frame: through study completion, an average of 18 months
Associated factors are : disease type (Crohn / Ulcerative colitis), gender, location of the disease at diagnosis, surgery, treatments, age at diagnosis
through study completion, an average of 18 months
Association between educational level and quality of life
Time Frame: through study completion, an average of 18 months
Quality of life as measured by SIBDQ questionnaire.
through study completion, an average of 18 months
Percentage of patients for whom the disease had an influence on the choice of studies
Time Frame: through study completion, an average of 18 months
This question is directly asked to the patient and reflects its own feeling
through study completion, an average of 18 months
Percentage of patients for whom the disease had an influence on the course of the studies
Time Frame: through study completion, an average of 18 months
This question is directly asked to the patient and reflects its own feeling
through study completion, an average of 18 months
Percentage of patients for whom the disease had an influence on the choice of profession
Time Frame: through study completion, an average of 18 months
This question is directly asked to the patient and reflects its own feeling
through study completion, an average of 18 months
Quality of life as measured by EQ5D-5L questionnaire
Time Frame: through study completion, an average of 18 months
Quality of life as measured by EQ5D-5L questionnaire and transformed into utility according to French reference values. Quality of life will be described according to age, disease activity and surgery.
through study completion, an average of 18 months
Disease activity for Crohn's patients
Time Frame: through study completion, an average of 18 months
As measured by HBI (Harvey-Bradshaw Index). Disease activity will be used to describe quality of life according to disease state and to assessed sensitivity to change of IBD-Disability Index.
through study completion, an average of 18 months
Disease activity for Ulcerative Colitis patients
Time Frame: through study completion, an average of 18 months
As measured by SCCAI questionnaire (Simple Clinical Colitis Activity Index). Disease activity will be used to describe quality of life according to disease state and to assessed sensitivity to change of IBD-Disability Index.
through study completion, an average of 18 months
Disability in 200 patients
Time Frame: through study completion, an average of 18 months
As measured by IBD-DI (IBD Disability Index) in 200 patients previously questioned in 2012 in order to address the question of sensitivity to change of IBD-DI. Measure of change is disease activity as measured by HBI-Index for Crohn's patients and SCCAI for Ulcerative Colitis patients.
through study completion, an average of 18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dominique Turck, MD,PhD, University Hospital, Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 28, 2019

Primary Completion (Actual)

January 28, 2023

Study Completion (Actual)

January 28, 2023

Study Registration Dates

First Submitted

May 10, 2021

First Submitted That Met QC Criteria

May 10, 2021

First Posted (Actual)

May 14, 2021

Study Record Updates

Last Update Posted (Actual)

May 22, 2026

Last Update Submitted That Met QC Criteria

May 20, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2017_19
  • 2017-A03397-46 (Other Identifier: ID-RCB number, ANSM)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Crohn Disease

Subscribe